DocDollars

Kuros Biosciences USA, Inc

GA · United States · Reporting entity ID 100000886825

Total reported 2019–2025
$2.18M
#992 of 2,960 reporting companies — 0% of all reported industry payments
$2.17M in general payments across 4,188 records, plus $15K in research funding across 2 records.

How it breaks down

General payments $2,166,493
Research funding $15,000

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Kuros Biosciences USA, Inc reported $2.18M to US doctors and teaching hospitals from 2019 to 2025, ranking #992 of 2,960 reporting companies. 1% of that was research funding and 99% general payments such as consulting, speaking, food and travel. 4,188 general payment records and 2 research records were filed.

Common questions about Kuros Biosciences USA, Inc

How much has Kuros Biosciences USA, Inc paid US doctors?

Kuros Biosciences USA, Inc reported $2,181,493 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,166,493 in general payments, $15,000 in research funding.

How does Kuros Biosciences USA, Inc rank among drug and device companies?

It ranks #992 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Kuros Biosciences USA, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.